Case Rep Dermatol 11(1):8285
Other GLP-1 Receptor Agonists: Taking semaglutide with other drugs in the same class (GLP-1 receptor agonists) is generally not recommended, as it can increase the risk of side effects without providing additional benefits
Although rare, more serious side effects can include infection, skin necrosis, and lumps at the injection site
While this is not a known direct effect of GLP-1 therapy, it still needs attention
Only eight FDA-approved facilities worldwide can produce GLP-1 peptides at scale, so any disruption, such as the 2024 fire at a Danish supplier, quickly triggers global shortages
"One thing we can do, is when were going down the grocery store aisle, flip the package over and read whats inside of it, Rich says